Vor Biopharma Inc. (VOR)
NASDAQ: VOR · Real-Time Price · USD
0.1725
+0.0212 (14.01%)
At close: May 12, 2025, 4:00 PM
0.1650
-0.0075 (-4.35%)
After-hours: May 12, 2025, 7:59 PM EDT
Vor Biopharma Market Cap
Vor Biopharma has a market cap or net worth of $21.54 million as of May 12, 2025. Its market cap has decreased by -81.86% in one year.
Market Cap
21.54M
Enterprise Value
-38.56M
1-Year Change
-81.86%
Ranking
Category
Stock Price
$0.17
Market Cap Chart
Since the IPO on February 5, 2021, Vor Biopharma's market cap has decreased from $1.30B to $21.54M, a decrease of -98.34%. That is a compound annual growth rate of -61.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 18.89M | -86.34% |
| Dec 31, 2024 | 138.24M | -9.38% |
| Dec 29, 2023 | 152.56M | -65.05% |
| Dec 30, 2022 | 436.57M | 0.75% |
| Dec 31, 2021 | 433.30M | -66.64% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 684.07B |
| Johnson & Johnson | 372.87B |
| UnitedHealth Group | 344.41B |
| AbbVie | 339.66B |
| Novo Nordisk | 292.03B |
| Abbott Laboratories | 230.68B |
| Novartis AG | 213.30B |
| AstraZeneca | 210.42B |